ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,511Medicare Part D Prescriptions Filled, Including Refills

Rank: 237 out of 890

$486K Total Retail Price of All Prescriptions

Rank: 255 out of 890

280 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 280 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

23% of this provider’s 280 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 7,031 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 379 255 S3 1 3
FUROSEMIDE 341 258 2 7
POTASSIUM CHLORIDE 291 248 3 11
OMEPRAZOLE 278 212 4 8
METOPROLOL TARTRATE 265 188 5 15
WARFARIN SODIUM 227 203 6 24
LEVOTHYROXINE SODIUM 199 151 7 2
TRAZODONE HCL 193 83 8 40
CYMBALTA 176 112 9 45
AMLODIPINE BESYLATE 162 135 10 1
ZOLPIDEM TARTRATE 156 114 11 19
METFORMIN HCL 150 108 12 6
CLOPIDOGREL 142 93 13 28
SIMVASTATIN 138 114 14 5
GABAPENTIN 134 85 15 12
FLUTICASONE PROPIONATE 127 100 16 39
DIOVAN 120 100 17 33
DICLOFENAC POTASSIUM 114 92 18 221
PAROXETINE HCL 114 82 18 68
LOVASTATIN 111 81 20 46
ENALAPRIL MALEATE 107 61 21 56
CARISOPRODOL 107 48 R 21 69
SPIRIVA 104 63 23 66
PRAVASTATIN SODIUM 103 91 24 10
POLYETHYLENE GLYCOL 3350 99 88 25 67
NEXIUM 93 52 26 14
CITALOPRAM HBR 92 72 27 20
DONEPEZIL HCL 86 85 28 30
PANTOPRAZOLE SODIUM 84 71 29 34
METOPROLOL SUCCINATE 83 71 30 17
PLAVIX 82 61 31 42
CLONIDINE HCL 81 40 32 35
CARVEDILOL 79 39 33 22
ISOSORBIDE MONONITRATE ER 79 50 33 60
ATORVASTATIN CALCIUM 77 63 35 13
PREDNISONE 77 45 35 47
NAMENDA 72 72 37 36
TRAMADOL HCL 71 58 38 16
ALLOPURINOL 70 54 39 31
ZETIA 69 46 40 81
DIGOXIN 65 59 41 65
KLOR-CON M20 64 43 42 72
INDAPAMIDE 63 63 43 148
NABUMETONE 63 56 43 143
SPIRONOLACTONE 61 60 45 85
CIPROFLOXACIN HCL 60 48 46 58
SERTRALINE HCL 58 34 47 26
SINGULAIR 55 40 48 79
SULFAMETHOXAZOLE-TRIMETHOPRIM 55 34 48 76
GUANFACINE HCL 54 54 R 50 233
AMLODIPINE BESYLATE-BENAZEPRIL 52 52 51 41
VENLAFAXINE HCL ER 52 46 51 114
METOCLOPRAMIDE HCL 50 33 53 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 21, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.